TEM – tempus ai, inc. - class a (US:NASDAQ)

News

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield [Yahoo! Finance]
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com